Documentos relacionados

1. Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports.
2. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
3. Cytokine changes in response to TPO receptor agonist treatment in primary immune thrombocytopenia.
4. Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura.
5. Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP.
6. Thrombopoietin receptor agonist switch in children with persistent and chronic severe immune thrombocytopenia: A retrospective analysis in a large tertiary center.
7. Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada.
8. Usefulness of thrombopoietin receptor agonists for persistent clinically relevant thrombocytopenia after allogeneic stem cell transplantation.
9. Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.
10. How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment.